Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Genetics: Eric Santa, Jeff Borcherding

Myriad Genetics has hired Eric Santa, previously chief revenue officer at UnitedHealth Group's Rally Health, as its new chief growth officer. Santa will report to Myriad CEO Paul Diaz and lead marketing, digital, branding, and communications initiatives that grow the company's presence and reach. He will also spearhead efforts to glean new genetic insights using Myriad's patient database and identify expansion opportunties. 

Additionally, Jeff Borcherding, previously a general manager leading sales and marketing efforts for the GeneSight pharmacogenetic test, has been promoted to senior VP and chief marketing officer within Santa's team. Borcherding will now focus on increasing test volumes and revenues within Myriad's integrated product marketing initiatives.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.